- Home
- BARK vs RVNC Comparison
BARK vs RVNC Comparison
Compare BARK & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BARK
- RVNC
- Stock Information
- Founded
- BARK 2011
- RVNC 1999
- Country
- BARK United States
- RVNC United States
- Employees
- BARK N/A
- RVNC N/A
- Industry
- BARK Department/Specialty Retail Stores
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- BARK Consumer Discretionary
- RVNC Health Care
- Exchange
- BARK Nasdaq
- RVNC Nasdaq
- Market Cap
- BARK 308.9M
- RVNC 320.5M
- IPO Year
- BARK N/A
- RVNC 2014
- Fundamental
- Price
- BARK $1.89
- RVNC $3.06
- Analyst Decision
- BARK Buy
- RVNC Hold
- Analyst Count
- BARK 2
- RVNC 9
- Target Price
- BARK $2.20
- RVNC $7.78
- AVG Volume (30 Days)
- BARK 1.1M
- RVNC 3.5M
- Earning Date
- BARK 02-05-2025
- RVNC 02-26-2025
- Dividend Yield
- BARK N/A
- RVNC N/A
- EPS Growth
- BARK N/A
- RVNC N/A
- EPS
- BARK N/A
- RVNC N/A
- Revenue
- BARK $488,881,000.00
- RVNC $256,945,000.00
- Revenue This Year
- BARK $3.23
- RVNC $11.28
- Revenue Next Year
- BARK $10.01
- RVNC $27.21
- P/E Ratio
- BARK N/A
- RVNC N/A
- Revenue Growth
- BARK N/A
- RVNC 25.82
- 52 Week Low
- BARK $0.74
- RVNC $2.30
- 52 Week High
- BARK $2.56
- RVNC $8.98
- Technical
- Relative Strength Index (RSI)
- BARK 45.84
- RVNC 33.65
- Support Level
- BARK $1.81
- RVNC $3.06
- Resistance Level
- BARK $1.94
- RVNC $3.09
- Average True Range (ATR)
- BARK 0.12
- RVNC 0.02
- MACD
- BARK -0.05
- RVNC 0.05
- Stochastic Oscillator
- BARK 15.69
- RVNC 37.50
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.